🔎 Trials Near Me

Akèy › Kansè Endomèt › Oregon › Eugene

Etid klinik pou Kansè Endomèt nan Eugene, OR

8 etid pou Kansè Endomèt ap chèche patisipan nan sit nan ak bò kote Eugene (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.

Tèks ofisyèl etid la (Anglè)

Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →

Study to Assess the Efficacy and Safety of Rina-S Compared to Treatment of Investigator's Choice in Participants With Endometrial Cancer

Ap rekriteFaz 3
  • Willamette Valley Cancer Institute and Research Center - Eugene, Eugene
Laj 18 ak plis · Fanm · Mizajou Sep 9, 2026 · NCT07166094

Rinatabart Sesutecan (Rina-S, PRO1184, GEN1184) for Advanced Solid Tumors (GCT1184-01/ PRO1184-001)

Ap rekriteFaz 1/2
  • USOR Oncology Associates of Oregon, P.C., Eugene
Laj 18 ak plis · Tout sèks · Mizajou Aug 4, 2026 · NCT05579366

Puxitatug Samrotecan (AZD8205) Monotherapy vs Chemotherapy in B7-H4-selected Endometrial Cancer (Bluestar-Endometrial01)

Ap rekriteFaz 3
  • Research Site, Eugene
Laj 18 ak plis · Fanm · Mizajou Jul 29, 2026 · NCT07044336

Relacorilant in Combination With Different Treatment Regimens in Patients With Gynecological Cancers

Ap rekriteFaz 2
  • 517, Eugene
Laj 18 ak plis · Fanm · Mizajou Jul 16, 2026 · NCT06906341

Sapanisertib and Serabelisib (PIKTOR) With Paclitaxel and a Substudy With an Insulin-Suppressing Diet in Patients With Advanced/Recurrent Endometrial Cancer

Ap rekriteFaz 2
  • Oncology Associates of Oregon, P.C., Eugene
Laj 18 ak plis · Fanm · Mizajou Dec 24, 2025 · NCT06463028

Study of Navtemadlin as Maintenance Therapy in TP53WT Advanced or Recurrent Endometrial Cancer

Ap rekriteFaz 2/3
  • Oncology Associates of Oregon, Eugene
Laj 18 ak plis · Fanm · Mizajou May 2, 2024 · NCT05797831

Etid Kansè Endomèt nan lòt vil

Lòt etid nan Eugene

Sous ClinicalTrials.gov, done yo ranmase Oct 5, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.